Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ming Zhou
Institution:
Icahn School of Medicine at Mount Sinai
Observed institution:
Icahn School of Medicine at Mount Sinai
ORCID:
0009-0003-7947-7003
Observed ORCID:
0009-0003-7947-7003
OpenAlex ID:
A5138840176
Is Gleason pattern 3 cancer? Molecular features do not distinguish pattern 3 from benign tissue
2026
·
Riccardo Leni
, Scott E. Eggener
, et al.
·
British Journal of Urology
·
2
Data from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
·
1
Figure S7 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Figure S1 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Figure S5 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Figure S2 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Figure S6 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Figure S4 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Figure S3 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Supplementary Table 1 from A Novel Bispecific Integrin α5β1/αv Antibody Reprograms the Myc-Regulated Basal Phenotype of Prostate Cancer with NK Cell–Mediated Tumor Elimination
2026
·
Raghav Joshi
, Ming Zhou
, et al.
Show more works
View as search
Works count:
10
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type